Evidence map›Paper›PMID 25361774›Full record

ArticleExperimental biology and medicine (Maywood, N.J.)2015

Beetroot juice reduces infarct size and improves cardiac function following ischemia-reperfusion injury: Possible involvement of endogenous H2S.

Fadi N Salloum, Gregory R Sturz, Chang Yin, Shabina Rehman, Nicholas N Hoke, Rakesh C Kukreja, Lei Xi

Open access · greenAbstract read
In one paragraph

Article in Experimental biology and medicine (Maywood, N.J.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Effect of pre-exercise dietary nitrate on skeletal muscle blood flow in a rat model of pulmonary hypertension.American journal of physiology. Regulatory, integrative and comparative physiology · 2025
    Article
  6. SQOR as a metabolic rheostat of HFrontiers in cell and developmental biology · 2025
    Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Regulatory effects of trimetazidine in cardiac ischemia/reperfusion injury.Naunyn-Schmiedeberg's archives of pharmacology · 2023
    Review
  13. Review
  14. Review
  15. Nutraceuticals in Chronic Coronary Syndromes: Preclinical Data and Translational Experiences.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2021
    Review
  16. Nutraceuticals in the Treatment of Pulmonary Arterial Hypertension.International journal of molecular sciences · 2020
    Review
  17. Article
  18. Review
  19. Review
  20. Hydrogen Sulfide (HFrontiers in pharmacology · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Fadi N SalloumPauley Heart Center, Division of Cardiology, Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA 23298, USA.
Gregory R SturzPauley Heart Center, Division of Cardiology, Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA 23298, USA.
Chang YinPauley Heart Center, Division of Cardiology, Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA 23298, USA.
Shabina RehmanPauley Heart Center, Division of Cardiology, Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA 23298, USA.
Nicholas N HokePauley Heart Center, Division of Cardiology, Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA 23298, USA.
Rakesh C KukrejaPauley Heart Center, Division of Cardiology, Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA 23298, USA.
Lei XiPauley Heart Center, Division of Cardiology, Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA 23298, USA lxi@vcu.edu.
Virginia Commonwealth University · US

Funding

Protection against Doxorubicin-Induced CardiomyopathyR37HL051045 · NHLBI · VIRGINIA COMMONWEALTH UNIVERSITY · PI KUKREJA, RAKESH C · 2006 to 2015
$3.8M
CARDIOPROTECTIVE EFFECTS OF PDE-5 INHIBITORSR01HL079424 · NHLBI · VIRGINIA COMMONWEALTH UNIVERSITY · PI KUKREJA, RAKESH C · 2005 to 2013
$3.6M
ROS, Inflammation, and Cardioprotection in Type 2 DiabetesR01HL118808 · NHLBI · VIRGINIA COMMONWEALTH UNIVERSITY · PI KUKREJA, RAKESH C · 2013 to 2017
$2.5M
SIGNALING MECHANISMS IN PHARMACOLOGICAL PRECONDITIONINGR01HL051045 · NHLBI · VIRGINIA COMMONWEALTH UNIVERSITY · PI KUKREJA, RAKESH C. · 1995 to 2004
$1.4M
NHLBI NIH HHS HL118808NHLBI NIH HHS HL51045NHLBI NIH HHS HL79424NHLBI NIH HHS R01 HL051045NHLBI NIH HHS R01 HL079424NHLBI NIH HHS R01 HL118808NHLBI NIH HHS R37 HL051045
6 · The paper itself

Abstract

Ingestion of high dietary nitrate in the form of beetroot juice (BRJ) has been shown to exert antihypertensive effects in humans through increasing cyclic guanosine monophosphate (cGMP) levels. Since enhanced cGMP protects against myocardial ischemia-reperfusion (I/R) injury through upregulation of hydrogen sulfide (H2S), we tested the hypothesis that BRJ protects against I/R injury via H2S. Adult male CD-1 mice received either regular drinking water or those dissolved with BRJ powder (10 g/L, containing ∼ 0.7 mM nitrate). Seven days later, the hearts were explanted for molecular analyses. Subsets of mice were subjected to I/R injury by occlusion of the left coronary artery for 30 min and reperfusion for 24 h. A specific inhibitor of H2S producing enzyme--cystathionine-γ-lyase (CSE), DL-propargylglycine (PAG, 50 mg/kg) was given i.p. 30 min before ischemia. Myocardial infarct size was significantly reduced in BRJ-fed mice (15.8 ± 3.2%) versus controls (46.5 ± 3.5%, mean ± standard error [SE], n = 6/group, P < .05). PAG completely blocked the infarct-limiting effect of BRJ. Moreover, BRJ significantly preserved ventricular function following I/R. Myocardial levels of H2S and its putative protein target--vascular endothelial growth factor receptor 2 (VEGFR2) were significantly increased by BRJ intake, whereas CSE mRNA and protein content did not change. Interestingly, the BRJ-induced cardioprotection was not associated with elevated blood nitrate-nitrite levels following I/R nor induction of cardiac peroxiredoxin 5, a mitochondrial antioxidant enzyme previously linked to nitrate-induced cardioprotection. We conclude that BRJ ingestion protects against post-I/R myocardial infarction and ventricular dysfunction possibly through CSE-mediated endogenous H2S generation. BRJ could be a promising natural and inexpensive nutraceutical supplement to reduce cardiac I/R injury in patients.

Indexed as

AnimalsBeta vulgarisBlotting, WesternHydrogen SulfideMaleMiceMyocardial InfarctionPolymerase Chain ReactionReperfusion InjuryHydrogen SulfidecardioprotectionH2Sischemia–reperfusion injurymyocardial infarctionNatural dietary supplementnitrate

Identifiers

PMID25361774
PMCPMC4935262
OpenAlexW2317707756

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.